• Sequel Develops Novel Insulin Delivery System in Next Wave of Diabetes Innovation

  • Dec 5 2024
  • Durée: 46 min
  • Podcast

Sequel Develops Novel Insulin Delivery System in Next Wave of Diabetes Innovation

  • Résumé

  • Sequel is combining the experience of its four co-founders to develop the next generation of insulin pumps, aiming to provide better delivery capabilities, CEO Alan Lotvin tells Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Lotvin sits down with BI analyst Matt Henriksson for an in-depth interview on the path insulin pumps have taken over the past 50 years to close in on a truly automated delivery system. They also discuss Sequel’s development of its twiist delivery system, designed to better titrate insulin injected into the body, and its strategy for commercial launch in 2025.

    See omnystudio.com/listener for privacy information.

    Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2

Ce que les auditeurs disent de Sequel Develops Novel Insulin Delivery System in Next Wave of Diabetes Innovation

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.